NCT05062421View on ClinicalTrials.gov

Persistence of Biological Treatment and Inhibitors of Jak Kinases in Patients With Rheumatoid Arthritis.

RecruitingOBSERVATIONAL
Enrollment

540

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

December 1, 2026

Study Completion Date

December 31, 2026

Conditions
Arthritis, Rheumatoid
Trial Locations (1)

41009

RECRUITING

Hospital Universitario Virgen macarena, Seville

All Listed Sponsors
lead

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

OTHER